These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 9258218)
41. [Diurnal variation curve of intraocular pressure and ocular pulse amplitude with dynamic contour tonometer in primary open-angle glaucoma and normal tension glaucoma patients]. Yun HM; Fu P; Yuan JS; Zhang B; Li XX Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3401-4. PubMed ID: 17313852 [TBL] [Abstract][Full Text] [Related]
42. 24-hour efficacy of the bimatoprost-timolol fixed combination versus latanoprost as first choice therapy in subjects with high-pressure exfoliation syndrome and glaucoma. Konstas AG; Holló G; Mikropoulos DG; Haidich AB; Dimopoulos AT; Empeslidis T; Teus MA; Ritch R Br J Ophthalmol; 2013 Jul; 97(7):857-61. PubMed ID: 23686322 [TBL] [Abstract][Full Text] [Related]
43. Comparison of ocular response analyzer parameters in primary open angle glaucoma and exfoliative glaucoma patients. Beyazyıldız E; Beyazyıldız O; Arifoğlu HB; Altıntaş AK; Köklü SG Indian J Ophthalmol; 2014 Jul; 62(7):782-7. PubMed ID: 25116770 [TBL] [Abstract][Full Text] [Related]
44. Deep sclerectomy for the treatment of exfoliation and primary open-angle glaucoma. Rekonen P; Kannisto T; Puustjärvi T; Teräsvirta M; Uusitalo H Acta Ophthalmol Scand; 2006 Aug; 84(4):507-11. PubMed ID: 16879572 [TBL] [Abstract][Full Text] [Related]
45. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension. Michaud JE; Friren B; Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685 [TBL] [Abstract][Full Text] [Related]
46. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Orzalesi N; Rossetti L; Bottoli A; Fumagalli E; Fogagnolo P Arch Ophthalmol; 2003 Apr; 121(4):453-7. PubMed ID: 12695241 [TBL] [Abstract][Full Text] [Related]
47. Diurnal intraocular pressure variations: an analysis of 690 diurnal curves. David R; Zangwill L; Briscoe D; Dagan M; Yagev R; Yassur Y Br J Ophthalmol; 1992 May; 76(5):280-3. PubMed ID: 1356429 [TBL] [Abstract][Full Text] [Related]
48. A short term study of the additive effect of timolol and brimonidine on intraocular pressure. Arici MK; Sayici M; Toker M; Erdoğan H; Topalkara A Eye (Lond); 2002 Jan; 16(1):39-43. PubMed ID: 11913886 [TBL] [Abstract][Full Text] [Related]
49. A comparison of once-daily morning vs evening dosing of concomitant latanoprost/timolol. Konstas AG; Nakos E; Tersis I; Lallos NA; Leech JN; Stewart WC Am J Ophthalmol; 2002 Jun; 133(6):753-7. PubMed ID: 12036665 [TBL] [Abstract][Full Text] [Related]
50. Comparison of different combinations of maximum medical therapy for lowering intraocular pressure in primary open angle glaucoma: 12-month retrospective consecutive case series. Joh HJ; Jin SW Jpn J Ophthalmol; 2019 Jul; 63(4):322-327. PubMed ID: 31115761 [TBL] [Abstract][Full Text] [Related]
51. Can mean central corneal thickness and its 24-hour fluctuation influence fluctuation of intraocular pressure? Fogagnolo P; Capizzi F; Orzalesi N; Figus M; Ferreras A; Rossetti L J Glaucoma; 2010 Aug; 19(6):418-23. PubMed ID: 19661818 [TBL] [Abstract][Full Text] [Related]
52. [Distribution of peak intraocular pressure in 24-hour and correlation between peak nocturnal intraocular pressure with diurnal intraocular pressure level in primary open angle glaucoma patients]. Cheng J; Sun X Zhonghua Yan Ke Za Zhi; 2015 Feb; 51(2):103-8. PubMed ID: 25908000 [TBL] [Abstract][Full Text] [Related]
53. The efficacy and safety of bimatoprost/timolol maleate, latanoprost/timolol maleate, and travoprost/timolol maleate fixed combinations on 24-h IOP. Guven Yilmaz S; Degirmenci C; Karakoyun YE; Yusifov E; Ates H Int Ophthalmol; 2018 Aug; 38(4):1425-1431. PubMed ID: 28616797 [TBL] [Abstract][Full Text] [Related]
54. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study. Sonty S; Mundorf TK; Stewart JA; Stewart WC Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877 [TBL] [Abstract][Full Text] [Related]
55. Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension. Day DG; Schacknow PN; Wand M; Sharpe ED; Stewart JA; Leech J; Stewart WC Am J Ophthalmol; 2003 Feb; 135(2):138-43. PubMed ID: 12566015 [TBL] [Abstract][Full Text] [Related]
56. A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group. Stewart WC; Laibovitz R; Horwitz B; Stewart RH; Ritch R; Kottler M Arch Ophthalmol; 1996 Aug; 114(8):938-42. PubMed ID: 8694728 [TBL] [Abstract][Full Text] [Related]
57. Mitomycin-C-augmented deep sclerectomy in patients with primary open-angle glaucoma and exfoliation glaucoma: a 1-year prospective study. Ollikainen M; Puustjärvi T; Rekonen P; Uusitalo H; Teräsvirta M Acta Ophthalmol; 2010 Feb; 88(1):20-6. PubMed ID: 19432842 [TBL] [Abstract][Full Text] [Related]
58. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study. Martínez A; Sánchez M Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468 [TBL] [Abstract][Full Text] [Related]
59. Concordance of diurnal intraocular pressure between fellow eyes in primary open-angle glaucoma. Dinn RB; Zimmerman MB; Shuba LM; Doan AP; Maley MK; Greenlee EC; Alward WL; Kwon YH Ophthalmology; 2007 May; 114(5):915-20. PubMed ID: 17467528 [TBL] [Abstract][Full Text] [Related]
60. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension. Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]